Market Size in 2022 | Market Forecast in 2030 | CAGR (in %) | Base Year |
---|---|---|---|
USD 13.27 Billion | USD 61.45 Billion | 21.46% | 2022 |
The global Surrogacy Market size was worth around USD 13.27 Billion in 2022 and is predicted to grow to around USD 61.45 Billion by 2030 with a compound annual growth rate (CAGR) of roughly 21.46% between 2023 and 2030.
Surrogacy is one of the keys assisted reproductive techniques wherein a woman, often by means of a legal agreement, carries the offspring of another couple. Couples who want to start or extend their families opt for this method. Altruistic (non-commercial) surrogacy, traditional surrogacy, and commercial surrogacy are three major types of surrogacy.
On the basis of the genetic origin of the egg, surrogacy can be classified into gestational and traditional. In traditional surrogacy, the participating woman’s eggs are utilized, rendering her the biological mother of the progeny, whereas gestational surrogacy does not involve any biological link with the child whatsoever.
On the basis of whether or not there is financial exchange involved, surrogacy can be divided into commercial and altruistic. Commercial surrogacy is the practice of renting out one’s womb to bear the child of another in exchange for money. In an altruistic surrogacy, however, no monetary benefits are offered to the surrogate mother, as she is often a close relation to the couple, although medical expenses might be taken care of.
As the incidence of hormonal imbalances and resulting infertility cases rises worldwide, the global surrogacy market will witness enormous growth over the forecast period. Age, genetics, sperm & egg production, and exposure to certain toxic chemicals can hamper human fertility.
Similarly, regular consumption of alcohol, use of steroids, and certain medical conditions such as diabetes can lower sperm count among men, leading to infertility issues. Amongst women, hormonal disorders, abnormal structure of the uterus or cervix, stress, blocked fallopian tubes, and particular medical conditions can trigger infertility. With the number of infertility problems increasing, the awareness regarding infertility treatments has also been growing.
As the number of fertility clinics has been multiplying rapidly over the last decade, the global surrogacy market will flourish to a considerable degree. The growing availability and utilization of new fertility treatments including in-vitro fertilization and egg or sperm donation will also exert a positive influence on the surrogacy market outlook over the forthcoming timeframe.
The alarming increase in the number of women diagnosed with polycystic ovaries disorder (PCOD) is also responsible for the progression of the global surrogacy market. According to the Centers for Disease Control and Prevention, nearly 5 million women of reproductive age in the US are affected by PCOD.
The stringent regulatory laws pertaining to the practice of surrogacy, alongside the high medical expenditure involved in the procedure can hamper the growth of the global surrogacy market over the forecast period.
The global surrogacy market can be segmented on the basis of type, technology, age group, service provider, and region. Traditional surrogacy and gestational surrogacy are the two chief categories by type.
By technology, in-vitro fertilization and intrauterine insemination (IUI) are the two key classifications. The in-vitro segment has further been divided into standard IVF and intracytoplasmic sperm injection. The age group segments in the global surrogacy market are less than 35, between 35 and 37, 38 to 39, 40 to 42, 43 to 44, and more than 44 years. The two prominent service providers are fertility clinics and hospitals.
Regionally, the Africa segment is expected to display the fastest growth through the projected timeline, thanks to the lack of implementation of stringent regulatory policies across the region. Nigeria is likely to lead the pack, owing to simplified legal terms and conditions associated with commercial surrogacy. The growth of the other regional segments will be negatively affected as a result of the commercial surrogacy practice being illegal in those nations.
Regional markets such as India, where commercial surrogacy was eventually declared illegal in 2018, will grow at a slow pace. The US, being a surrogacy-friendly nation, will also contribute toward the growth of the market. The lack of a legal framework regarding surrogacy across Malaysia will also prove beneficial for the growth of the global surrogacy market.
Report Attributes | Report Details |
---|---|
Report Name | Surrogacy Market Size Report |
Market Size in 2022 | USD 13.27 Billion |
Market Forecast in 2030 | USD 61.45 Billion |
Growth Rate | CAGR of 21.46% |
Number of Pages | 188 |
Forecast Units | Value (USD Billion), and Volume (Units) |
Key Companies Covered | AVA Clinic Scanfert, Nova IVI Fertility, Cardone and Associates Reproductive Medicine & Infertility, New Hope Fertility Center, Ovation Fertility, IVI-RMA GLOBAL, and Extraordinary Conceptions |
Segments Covered | By Type,BY Technology, By Age group, By Service provider, By region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East and Africa (MEA) |
Countries Covered | North America: U.S and Canada Europe: Germany, Italy, Russia, U.K, Spain, France, Rest of Europe APAC: China, Australia, Japan, India, South Korea, South East Asia, Rest of Asia Pacific Latin America: Brazil, Argentina, Chile The Middle East And Africa: South Africa, GCC, Rest of MEA |
Base Year | 2022 |
Historical Year | 2017 to 2021 |
Forecast Year | 2023 - 2030 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
What Reports Provides
FrequentlyAsked Questions
The global Surrogacy Market size was worth around USD 13.27 Billion in 2022 and is predicted to grow to around USD 61.45 Billion by 2030
The CAGR value of the safety service market is expected to be around 21.46% during 2023-2030.
The global Surrogacy Market is expected to witness the highest growth in North America since currently, the US is the contributor amongst all other regions
AVA Clinic Scanfert, Nova IVI Fertility, Cardone and Associates Reproductive Medicine & Infertility, New Hope Fertility Center, Ovation Fertility, IVI-RMA GLOBAL, and Extraordinary Conceptions
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed